Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

Bellerophon Therapeutics, Inc. (BLPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/03/2023 3 Kim Bobae (VP Reg. Affairs & Quality) has filed a Form 3 on Bellerophon Therapeutics, Inc.
10/08/2021 3 Laccona Nicholas (Controller, (PFO & PAO)) has filed a Form 3 on Bellerophon Therapeutics, Inc.
09/11/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
03/27/2019 3 Teufel Crispin (Director) has filed a Form 3 on Bellerophon Therapeutics, Inc.
08/16/2018 3 VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc.
08/16/2018 3 VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc.
04/13/2018 3 Puissance Cross-Border Opportunities III LLC (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc.
03/30/2018 3 BENNETT MATTHEW (Director) has filed a Form 3 on Bellerophon Therapeutics, Inc.
01/17/2018 3 Korner Assaf (CFO) has filed a Form 3 on Bellerophon Therapeutics, Inc.
12/04/2017 3 Wang Theodore T (10% Owner) has filed a Form 3 on Bellerophon Therapeutics, Inc.
03/16/2017 3 Schoeps Megan (Principal Financial Officer) has filed a Form 3 on Bellerophon Therapeutics, Inc.
05/04/2016 3 Shah Parag Suresh (VP Proj Mgmt & Distribution) has filed a Form 3 on Bellerophon Therapeutics, Inc.
03/01/2016 3 Tenenbaum Fabian (CFO & Chief Business Officer) has filed a Form 3 on Bellerophon Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy